Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Total Current Liabilities (2021 - 2025)

Century Therapeutics has reported Total Current Liabilities over the past 5 years, most recently at $20.2 million for Q4 2025.

  • Quarterly Total Current Liabilities fell 84.42% to $20.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.2 million through Dec 2025, down 84.42% year-over-year, with the annual reading at $20.2 million for FY2025, 84.42% down from the prior year.
  • Total Current Liabilities was $20.2 million for Q4 2025 at Century Therapeutics, down from $22.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $129.8 million in Q4 2024 and troughed at $14.5 million in Q1 2025.
  • The 5-year median for Total Current Liabilities is $20.2 million (2025), against an average of $26.9 million.
  • Year-over-year, Total Current Liabilities soared 627.23% in 2024 and then tumbled 84.42% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $15.7 million in 2021, then surged by 90.46% to $29.8 million in 2022, then plummeted by 40.15% to $17.8 million in 2023, then soared by 627.23% to $129.8 million in 2024, then tumbled by 84.42% to $20.2 million in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Total Current Liabilities are $20.2 million (Q4 2025), $22.0 million (Q3 2025), and $14.9 million (Q2 2025).